Yvonne L. Greenstreet received $11.5M in total compensation as MBChB, MBA (10) Chief Executive Officer (principal executive officer) of ALNYLAM PHARMACEUTICALS, INC. in FY2024. The largest component was $3.6M in stock awards. That’s up 29% from FY2023. Source: SEC DEF 14A.
Executive Compensation Summary for ALNYLAM PHARMACEUTICALS, INC.
Yvonne L. Greenstreet Salary and Compensation - ALNYLAM PHARMACEUTICALS, INC. CEO Pay 2024
In fiscal year 2024, Yvonne L. Greenstreet, MBChB, MBA (10) Chief Executive Officer (principal executive officer) of ALNYLAM PHARMACEUTICALS, INC. (ALNY), received total compensation of $11.5 million.
Yvonne L. Greenstreet's compensation breakdown includes: base salary of $1.3 million, stock awards valued at $3.6 million, option awards of $3.6 million, non-equity incentive compensation of $3.0 million, and other compensation of $25K.
Compared to fiscal year 2023, Yvonne L. Greenstreet's total compensation increased 29% from $8.9 million to $11.5 million.
ALNYLAM PHARMACEUTICALS, INC. (ALNY) Executive Pay 2024
ALNYLAM PHARMACEUTICALS, INC.'s top 5 named executive officers received combined total compensation of $23.6 million in fiscal year 2024.
The named executive officers disclosed in ALNYLAM PHARMACEUTICALS, INC.'s 2024 proxy statement are:Yvonne L. Greenstreet (MBChB, MBA (10) Chief Executive Officer (principal executive officer)) with total compensation of $11.5 million, Jeffrey V. Poulton (Executive Vice President Chief Financial Officer (principal financial officer)) with total compensation of $3.8 million, Pushkal Garg (M.D. Executive Vice President, Chief Medical Officer) with total compensation of $2.9 million, Tolga Tanguler (Executive Vice President Chief Commercial Officer) with total compensation of $2.8 million, and Kevin J. Fitzgerald (Ph.D. Executive Vice President, Chief Scientific Officer) with total compensation of $2.7 million.